hemeonclinx Medical News about non-small cell lung cancer; Livin; Smac proteins

Email This Article

Save in My Library

Free Abstract

Yang C-L et al. - Overexpression of Livin protein may play a promoting role in the occurrence and progression of NSCLC. Moreover, it may bring an adverse effect on patients’ prognosis. Although overexpression of Smac protein affects the occurrence and progression of NSCLC, it has no relationship with the prognosis. Livin protein may be helpful to evaluate the progression of NSCLC, and to predict the prognosis.

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 08/07/08

Antibiotic use predicts an increased risk of cancer
International Journal of Cancer, 08/20/08

Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 08/21/08

...All of Basic Science/Genetics

--- DIAGNOSTICS/RADIOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

How we diagnose the antiphospholipid syndrome
Blood, 09/16/08

Whole-body PET/CT-mammography for staging breast cancer
British Journal of Radiology, 09/15/08

PET scanning and prognosis in Hodgkins lymphoma
Current Opinion in Oncology, 09/02/08

...All of Diagnostics/Radiology

Sponsor

--- LUNG/THORACIC ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: A randomized phase III trial
Journal of Clinical Oncology, 09/15/08

Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapy
Journal of Thoracic Oncology, 09/08/08

Gefitinib versus vinorelbine in chemotherapy-naïve elderly patients with advanced non–small-cell lung cancer (INVITE): A randomized, phase II study
Journal of Clinical Oncology, 09/15/08

...All of Lung/Thoracic Oncology